These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33004283)

  • 21. Population Based Analysis of Gender Disparities in 23,715 Percutaneous Endovascular Revascularisations in the Metropolitan Area of Hamburg.
    Behrendt CA; Bischoff MS; Schwaneberg T; Hohnhold R; Diener H; Debus ES; Rieß HC
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):658-665. PubMed ID: 30902607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher Inpatient Mortality for Women after Intervention for Lifestyle Limiting Claudication.
    Miller SM; Sumpio BJ; Miller MS; Erben Y; Cordova AC; Sumpio BE
    Ann Vasc Surg; 2019 Jul; 58():54-62. PubMed ID: 30910650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality Indicators in Peripheral Arterial Occlusive Disease Treatment: A Systematic Review.
    Hischke S; Rieß HC; Bublitz MK; Kriston L; Schwaneberg T; Härter M; Bertges D; S Debus E; Behrendt CA
    Eur J Vasc Endovasc Surg; 2019 Nov; 58(5):738-745. PubMed ID: 31526633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors of 30-day unplanned readmission after lower extremity bypass.
    McPhee JT; Barshes NR; Ho KJ; Madenci A; Ozaki CK; Nguyen LL; Belkin M
    J Vasc Surg; 2013 Apr; 57(4):955-62. PubMed ID: 23332242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease.
    Siracuse JJ; Giles KA; Pomposelli FB; Hamdan AD; Wyers MC; Chaikof EL; Nedeau AE; Schermerhorn ML
    J Vasc Surg; 2012 Apr; 55(4):1001-7. PubMed ID: 22301210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
    Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
    J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories): Overview of Design and Rationale of an International Prospective Peripheral Arterial Disease Study.
    Smolderen KG; Gosch K; Patel M; Jones WS; Hirsch AT; Beltrame J; Fitridge R; Shishehbor MH; Denollet J; Vriens P; Heyligers J; Stone MEd N; Aronow H; Abbott JD; Labrosciano C; Tutein-Nolthenius R; A Spertus J
    Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e003860. PubMed ID: 29440123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends and Factors Associated With Peripheral Vascular Interventions for the Treatment of Claudication From 2011 to 2022: A National Medicare Cohort Study.
    Dun C; Stonko DP; Bose S; Keegan AC; McDermott KM; Rumalla KC; Black JH; Kalbaugh CA; Makary MA; Hicks CW
    J Am Heart Assoc; 2024 Jul; 13(14):e033463. PubMed ID: 38958132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
    Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal trends in peripheral arterial interventions: Observations from the blue cross blue shield of michigan cardiovascular consortium (BMC2 PVI).
    Thomas MP; Jung Park Y; Grey S; Schreiber TL; Gurm HS; Leffler D; Davis TP; Henke P; Michael Grossman P
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):728-734. PubMed ID: 28239949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protocol for a prospective, longitudinal cohort study on the effect of arterial disease level on the outcomes of supervised exercise in intermittent claudication: the ELECT Registry.
    van den Houten MM; Jansen SC; Sinnige A; van der Laan L; Vriens PW; Willigendael EM; Lardenoije JH; Elshof JM; van Hattum ES; Lijkwan MA; Nyklíček I; Rouwet EV; Koelemay MJ; Scheltinga MR; Teijink JA
    BMJ Open; 2019 Feb; 9(2):e025419. PubMed ID: 30782932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Part two: against the motion. endovascular therapy is the preferred treatment for patients <65 years old with symptomatic infrainguinal arterial disease.
    Houbballah R; Raux M; LaMuraglia G
    Eur J Vasc Endovasc Surg; 2012 Aug; 44(2):116-9. PubMed ID: 22878046
    [No Abstract]   [Full Text] [Related]  

  • 33. Editor's Choice - Long Term Survival after Femoropopliteal Artery Revascularisation with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis.
    Behrendt CA; Sedrakyan A; Peters F; Kreutzburg T; Schermerhorn M; Bertges DJ; Larena-Avellaneda A; L'Hoest H; Kölbel T; Debus ES
    Eur J Vasc Endovasc Surg; 2020 Apr; 59(4):587-596. PubMed ID: 31926836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between health status and sociodemographic, clinical and treatment disparities in the Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT) registry.
    Noyes AM; Abbott JD; Gosch K; Smolderen K; Spertus JA; Hyder O; Soukas P; Shishehbor MH; Aronow HD
    Vasc Med; 2018 Feb; 23(1):32-38. PubMed ID: 29338591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of sex on angioplasty and primary stenting for femoropopliteal occlusive disease: results of the DURABILITY II trial.
    Tadros RO; Faries PL; Rocha-Singh KJ; Kim Sy; Malik RK; Ellozy SH; Marin ML; Vouyouka AG
    Ann Vasc Surg; 2014 Jan; 28(1):1-9. PubMed ID: 24189009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding opportunities to understand quality and outcomes of peripheral vascular interventions: The ACC NCDR PVI Registry.
    Jones WS; Kennedy KF; Hawkins BM; Attaran RR; Secemsky EA; Latif F; Shammas NW; Feldman DN; Aronow HD; Gray B; Armstrong EJ; Grossman PM; Ho KKL; Prasad A; Jaff MR; Rosenfield K; Tsai TT
    Am Heart J; 2019 Oct; 216():74-81. PubMed ID: 31419621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of adjunct femoral endarterectomy in lower extremity bypass on perioperative and 1-year outcomes.
    Soden PA; Zettervall SL; Shean KE; Deery SE; Kalish JA; Healey CT; Kansal N; Schermerhorn ML;
    J Vasc Surg; 2017 Mar; 65(3):711-719.e1. PubMed ID: 27633166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences and long-term clinical outcomes in patients with chronic total occlusions of infrainguinal lower limb arteries treated from retrograde access with peripheral vascular interventions.
    Pawlik A; Januszek R; Ruzsa Z; Óriás V; Kleczyński P; Wojtasik-Bakalarz J; Arif S; Nyerges A; Chyrchel M; Stanek A; Dudek D; Bartuś S
    Adv Med Sci; 2020 Mar; 65(1):197-201. PubMed ID: 32014808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional Differences in Case Mix and Peri-operative Outcome After Elective Abdominal Aortic Aneurysm Repair in the Vascunet Database.
    Mani K; Venermo M; Beiles B; Menyhei G; Altreuther M; Loftus I; Björck M
    Eur J Vasc Endovasc Surg; 2015 Jun; 49(6):646-652. PubMed ID: 25752419
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.